Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02431598 · ClinicalTrials.gov registry record · Phase 4
Eovist vs. Dotarem Healthy Volunteer MRI
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT02431598 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 44 participants.
The verdict
NCT02431598, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in volunteer breath-holding capacity in response to gadoxetate disodium (Eovist) administration, compared with saline, and gadoterate dimeglumine (Dotarem). Healthy volunteers will be recruited from three study sites. These subjects will be given three, blinded, randomized injections while undergoing an MRI of their liver and holding their breath. During the scan, the subjects' oxygen saturation and heart rate will be closely monitored. Following the scan, the subjects will complete a questionnaire regarding the breath hold.
Interventions
- DRUG Saline
- DRUG gadoxetate disodium
- DRUG gadoterate dimeglumine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-06 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02431598
The ClinicalTrials.gov registry entry for NCT02431598 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT02431598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02431598 about?
NCT02431598 is a clinical study titled "Eovist vs. Dotarem Healthy Volunteer MRI". The purpose of this study is to evaluate changes in volunteer breath-holding capacity in response to gadoxetate disodium (Eovist) administration, compared with saline, and gadoterate dimeglumine (Dotarem). Healthy volunteers will be recruited from three study sites. These subjects will be given thre...
What is the current status of trial NCT02431598?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2015-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02431598?
The interventions under investigation include: Saline (DRUG), gadoxetate disodium (DRUG), gadoterate dimeglumine (DRUG).
Who is sponsoring clinical trial NCT02431598?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.